train station
ep exce consensu ep
slightli better revenu profit re-affirmed core
busi adj claim growth expect achiev
retent rate excess vs prior encourag
dynam rais ep reflect beat
monument chang forward assumpt
organ profit ahead adj claim slightli plan
lower core adj claim vs estimate exclud transit
account gross margin rose bp administr expens
higher bp contribut ebit margin expans bp
value-ad
solutions/specialti flow million cash reserv
stand billion note esrx reiter provid updat guidanc
light impend acquisit
rose
updeal closur esrx share may rise latest line report
consist oper target narrow spread close
view acquisit esrx highli probabl follow
doj recent endors sept await updat
outstand state approv earn releas tomorrow
deal abandon esrx
competit advantag independ pbm model deal address
grow role value-bas care paradigm also acknowledg
rhetor washington driven heighten volatil suppli
though view recent
commentari hh secretari offer relief focu
potenti shift complet remov rebat safe harbor po
capabl preserv power negoti tool pbm offer
greater transpar consum note esrx previous disclos
retain million rebat remaind passed-through
consumers/pay exclud value-bas reimburs esrx pdp
ideolog
valuat metric
number share
price month
 close
suiss seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis
express script stand-alon pharmaceut benefit manag
manag drug spend client
profit tax
chang work capit
flow oper
free cash-flow firm
flow invest
chang net cash/debt
total liabil equiti
share wtd average
price book
roe stated-return
scenario base view success
deal completet increment upsid share
grey scenario base valuat prior
announc acquir esrx larg driven esrx
valu proposit stand-alone pbm
 close
compani mention price
